Resolvins: A Novel Class of Drugs Modulating Innate Immunity

Discovered by researchers at Harvard, Resolvins are a novel class of "Immunoresolvents" that resolve inflammation and promote clearance of debris (phagocytosis) and healing. Unlike traditional anti-inflammatory drugs that inhibit immune function, Resolvins are agonists that regulate innate immunity without compromising host defense.

Our Technology

Despite promising biology, Resolvin development has been limited due to inherent physical-chemical challenges. Our HEALER technology overcomes these hurdles to enable the pharmaceutical development of Resolvins as new molecules with enhanced stability, formulation properties, and patent protection.


Resolvin Biology

Novel agonists of inflammation resolution


HEALER™ Platform

Fundamentally enabling technology


Intellectual Property

Long-term composition of matter patents

"It is time to challenge current treatment practices—namely, using inhibitors and
antagonists alone—and to develop immunoresolvents as agonists of resolution pharmacology."

- Serhan, C.N. FASEB J (2017).